Current Month
Article Features
  Artificial Intelligence Expedites Breast Cancer Risk Prediction
Breast Cancer Cells Found to Switch Molecular Characteristics
Expecting the Worst Increases Side-Effects in Breast Cancer Patients on Hormone Therapies
How Often Should You Have a Mammogram? Breast Density and Risk Can Inform Decision
Needle Biopsies for Noninvasive Breast Cancer: Routine Analysis Wastes Millions
New Approach to "Control" Cancer, Not “Eliminate” It
New DCIS Consensus Guideline Could Curb Unnecessary Breast Surgery and Reduce Health System Costs
New Standard Helps Ensure Accurate Clinical Measurements of HER2 Breast Cancer Gene
Novel Tracer Safely and Effectively Maps Sentinel Lymph Nodes in Breast Cancer Patients
Obesity on the Rise in Adults with a History of Cancer
One of the Most Common Viruses in Humans May Promote Breast Cancer Development
Patients with Cancer at Heightened Risk of Injuries During Diagnosis
Prevalence of Estrogen Receptor Mutations in Patients with Metastatic Breast Cancer
Racial Disparity in Breast Reconstruction? African-American Women More Likely to Undergo Autologous Reconstruction
Radiologists Detect Breast Cancer in "Blink of an Eye"
Research Reveals Patient Can Have More Than One Breast Cancer, Points at Treatments
Researchers Restore Drug Sensitivity in Breast Cancer Tumors
Study Confirms Long-Term Effects of “Chemobrain” in Mice


Expecting the Worst Increases Side-Effects in Breast Cancer Patients on Hormone Therapies

A study of women receiving hormone therapies such as tamoxifen as part of their treatment for breast cancer has found that the number and seriousness of side-effects they experienced were influenced by their expectations.

The study, which is published in the journal Annals of Oncology, found that women who had higher expectations of suffering more and worse side-effects before their treatment began did, in fact, experience more after two years of adjuvant hormone therapy. They experienced nearly twice the number of side-effects than did women with positive expectations or who thought the effects would not be too bad.

The researchers say that their findings are important because women may stop taking their adjuvant hormone treatment if they experience too many side-effects and worse health-related quality of life; this, in turn, can affect the success of treatment and survival. However, if expectations can predict the risk of experiencing side-effects, then interventions such as counseling could lower the risk and, therefore, improve adherence to medication.

Professor Yvonne Nestoriuc, of the Department of Psychosomatic Medicine and Psychotherapy at the University Medical Centre, Hamburg, Germany, who led the study, said: "Our results show that expectations constitute a clinically relevant factor that influences the long-term outcome of hormone therapy. Expectations can be modified so as to decrease the burden of long-term side-effects and optimize adherence to preventive anti-cancer treatments in breast cancer survivors."

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon